LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Feb 19, 2026, 4:00 PM EST
LadRx Market Cap
LadRx has a market cap or net worth of $693 as of February 20, 2026. Its market cap has decreased by -99.94% in one year.
Market Cap
693.00
Enterprise Value
-206.26K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 693.00, a decrease of -100.00%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 51.24K | 840.91% |
| Dec 29, 2025 | 5.45K | -99.35% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 105.79K |
| Innovation Pharmaceuticals | 105.75K |
| Itoco | 85.64K |
| PaxMedica | 75.76K |
| Affymax | 74.49K |
| Vincerx Pharma | 66.74K |
| U.S. Stem Cell | 66.15K |
| Panbela Therapeutics | 53.89K |